JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers
Study to Evaluate the Safety and Performance of the JetTouch Needle-Free Endoscopic Injection System to Deliver Saline Into the Bladder Wall of Healthy Subjects
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE1 9RT
- Guy's Hospital / Quintiles, Ltd.
-
Sheffield, United Kingdom
- Sheffield Teaching Hospitals NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy individuals (male and female) aged 18-55 without urinary complaints or documented urinary tract dysfunctions.
Exclusion Criteria:
- Unable or unwilling to sign Informed Consent Form or comply with study requirements
- Non-English speaking
- Currently enrolled in another clinical trial
- Undergone treatments given into the bladder in the past 4 weeks
- Female subject and has a positive urine pregnancy test at the time of screening/procedure or intends to become pregnant while enrolled
- Female subject and is currently breast feeding
- Female subject and has given birth in past 6 months
- Current or history of chronic urinary tract infections
- Current or history of chronic hematuria
- Current or history of bladder cancer
- History of major surgery in the last 6 months
- Current or history of bleeding disorders
- Currently taking anticoagulants
- Taking aspirin and is unable to discontinue treatment for 2 weeks prior to bladder injection
- Taking NSAIDS and is unable to discontinue 48 hours prior to bladder injection
- Platelet count, prothrombin time/INR (PT/INR) and partial thromboplastin time (PTT) outside the normal limits of the laboratories established reference ranges
- Current or history of any of the following: neurogenic bladder, radiation to pelvic area, inflammation of the bladder wall because of tuberculosis, schistosomiasis, bladder or ureteric calculi
- Known hypersensitivity to any of the agents used in the injection (FLEXLINE-Bladder® Attachment material, lidocaine, saline, Indigo Carmine dye or Ciprofloxacin)
- Current or history of any medical condition that in the opinion of the Investigator would make them an unsuitable candidate for this study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: JetTouch injections
|
Needle-free injection system believed to provide consistent and reliable delivery of material to the bladder wall.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety of the JetTouch system to deliver saline into the bladder wall.
Time Frame: within 14 days of the JetTouch procedure
|
within 14 days of the JetTouch procedure
|
|
Ability of the JetTouch system to deliver saline into the bladder wall.
Time Frame: At the JetTouch procedure
|
At the JetTouch procedure
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Physician feedback on the use of the JetTouch system.
Time Frame: At the JetTouch Procedure
|
At the JetTouch Procedure
|
|
Physician feedback on perceived subject tolerability of the JetTouch injection procedure.
Time Frame: At the JetTouch procedure.
|
At the JetTouch procedure.
|
|
Subject feedback question regarding the procedure.
Time Frame: At the JetTouch procedure
|
At the JetTouch procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Christopher R Chapple, BSc MD DHC FRCS (Urol) FEBU, Consultant Urological Surgeon, Royal Hallamshire Hospital
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- OT1202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.